0001567619-22-004417.txt : 20220214
0001567619-22-004417.hdr.sgml : 20220214
20220214164906
ACCESSION NUMBER: 0001567619-22-004417
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
EFFECTIVENESS DATE: 20220214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CPMG Inc
CENTRAL INDEX KEY: 0001372218
IRS NUMBER: 770616887
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18547
FILM NUMBER: 22633764
BUSINESS ADDRESS:
STREET 1: 2000 MCKINNEY
STREET 2: SUITE 2125
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: 214-871-6816
MAIL ADDRESS:
STREET 1: 2000 MCKINNEY
STREET 2: SUITE 2125
CITY: DALLAS
STATE: TX
ZIP: 75201
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001372218
XXXXXXXX
12-31-2021
12-31-2021
CPMG Inc
2000 MCKINNEY
SUITE 2125
DALLAS
TX
75201
13F HOLDINGS REPORT
028-18547
Y
This Form 13F includes only the reportable 2,896,901 Class A shares of Reata Pharmaceuticals, Inc. ("Reata") over which CPMG, Inc. ("CPMG") had investment discretion as of June 30, 2021. This Form 13F does not include the 1,692,857 Class B shares of Reata over which CPMG had investment discretion as of June 30, 2021 because such Class B shares were not included in the relevant quarter's Official List of Section 13(f) Securities, and thus should be excluded.
John E. Bateman
Chief Operating Officer
214-871-6816
/s/ John E. Bateman
Dallas
TX
02-14-2022
0
5
542281
false
INFORMATION TABLE
2
form13fInfoTable.xml
APOLLO ENDOSURGERY INC
COM
03767D108
32698
3878742
SH
SOLE
3878742
0
0
INSTIL BIO INC
COM
45783C101
145072
8478790
SH
SOLE
8478790
0
0
INVESCO QQQ TR
UNIT SER 1
46090E103
7441
18704
SH
SOLE
18704
0
0
PROCEPT BIOROBOTICS CORP
COM
74276L105
280679
11222662
SH
SOLE
11222662
0
0
REATA PHARMACEUTICALS INC
CL A
75615P103
76391
2896901
SH
SOLE
2896901
0
0